Hawaii Administrative Rules › Title 11 - DEPARTMENT OF HEALTH › Subtitle 1 - GENERAL DEPARTMENTAL PROVISIONS › Chapter 266.1 - HAZARDOUS WASTE MANAGEMENT: STANDARDS FOR THE MANAGEMENT OF SPECIFIC HAZARDOUS WASTES AND SPECIFIC TYPES OF HAZARDOUS WASTE MANAGEMENT FACILITIES › Part 266 - STANDARDS FOR THE MANAGEMENT OF SPECIFIC HAZARDOUS WASTES AND SPECIFIC TYPES OF HAZARDOUS WASTE MANAGEMENT FACILITIES › Subpart P - Hazardous Waste Pharmaceuticals and Hazardous Waste Electronic Nicotine Delivery Systems › Section 11-266.507 - Residues of hazardous waste pharmaceuticals or hazardous waste electronic nicotine delivery systems in empty containers

Current through June, 2024
(a) Stock,
					 dispensing and unit-dose containers. A stock bottle, dispensing bottle, vial,
					 or ampule (not to exceed 1 liter or 10,000 pills); or a unit-dose container
					 (e.g., a unit-dose packet, cup, wrapper, blister pack, or delivery device) is
					 considered empty and the residues are not regulated as hazardous waste provided
					 the pharmaceuticals have been removed from the stock bottle, dispensing bottle,
					 vial, ampule, or the unit-dose container using the practices commonly employed
					 to remove materials from that type of container. Nicotine e-liquid vials
					 packaged for retail sale in electronic nicotine delivery systems (not to exceed
					 1 liter) are considered empty and the residues are not regulated as hazardous
					 waste provided the liquid has been removed by pouring out the
					 contents.
(b) Syringes. A syringe
					 is considered empty and the residues are not regulated as hazardous waste under
					 this subpart provided the contents have been removed by fully depressing the
					 plunger of the syringe. If a syringe is not empty, the syringe must be placed
					 with its remaining hazardous waste pharmaceuticals into a container that is
					 managed and disposed of as a non-creditable hazardous waste pharmaceutical
					 under this subpart and any applicable federal, state, and local requirements
					 for sharps containers and medical waste.
(c) Intravenous (IV) bags. An IV bag is
					 considered empty and the residues are not regulated as hazardous waste provided
					 the pharmaceuticals in the IV bag have been fully administered to a patient. If
					 an IV bag is not empty, the IV bag must be placed with its remaining hazardous
					 waste pharmaceuticals into a container that is managed and disposed of as a
					 non-creditable hazardous waste pharmaceutical under this subpart, unless the IV
					 bag held non-acute hazardous waste pharmaceuticals and is empty as defined in
					 § 261.7(b)(1).
(d) Other
					 containers, including delivery devices. Hazardous waste pharmaceuticals
					 remaining in all other types of unused, partially administered, or fully
					 administered containers must be managed as non-creditable hazardous waste
					 pharmaceuticals under this subpart, unless the container held nonacute
					 hazardous waste pharmaceuticals and is empty as defined in § 261.7(b)(1)
					 or (2). This includes, but is not limited to, residues in inhalers, aerosol
					 cans, nebulizers, tubes of ointments, gels, or creams. Electronic nicotine
					 delivery systems (including attached or attachable cartridges, pods, or tanks)
					 that are unused, partially used, or fully used must be managed as
					 non-creditable subpart P hazardous waste, except empty vials described in
					 paragraph (a)